Chinese AntiphosPholipid Syndrome cohorT cOllaborative NEtworks

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Anti Phospholipid Syndrome
Trial Locations (18)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

101300

RECRUITING

Beijing Shunyi Hospital, Beijing

110001

RECRUITING

The First Hospital of China Medical University, Shenyang

116031

RECRUITING

The Second Affiliated Hospital of Dalian Medical University, Dalian

200025

RECRUITING

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

210029

RECRUITING

Jiangsu Province Hospital, Nanjing

250012

RECRUITING

Qilu Hospital of Shandong University, Jinan

300052

RECRUITING

Tianjin Medical University Genral Hospital, Tianjin

311202

RECRUITING

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

330006

RECRUITING

The Second Affiliated Hospical of Nanchang University, Nanchang

350001

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

510150

RECRUITING

The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou

518020

RECRUITING

Shenzhen People's Hospital, Shenzhen

518035

RECRUITING

The Second People's Hospital of Shenzhen, Shenzhen

530021

RECRUITING

The First Affiliated Hospital of Guangxi Medical University, Nanning

650032

RECRUITING

First Affiliated Hospital of Kunming Medical University, Kunming

RECRUITING

First People's Hospital of Yunnan Province, Kunming

010110

RECRUITING

The Affilicated Hospital of Inner Mongolia Medical University, Hohhot

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER